PRENATAL GENETIC SERVICES

Everything you need for Healthy Baby

Despite the continuous technological advances in modern medicine, it is our untimely reality that many preliminary mothers are still experiencing difficulties. In order to overcome the difficulties, medical treatment has been the main focus, but at the same time, a comprehensive diagnosis focusing on screening tests is needed to conceive a healthy baby. We provide state-of-the-art genetic diagnostic technology to test not only the fetus but also the health of women.

NIPT
(Non-Invasive Prenatal Test)

“Non-Invasive Prenatal Test (NIPT)" is the fetal genome screening of chromosomal abnormalities and the fetal genome tests have been bore up to high-risk pregnant women. 

 

Thanks to the newest NGS technologies, chromosomal abnormalities are non-invasively detectable with over 99% confident sensitivity and specificity level.

GENOMOM

PGS

(Preimplantation Genetic Screening)

Preimplantation genetic screening (PGS) for aneuploidy is a powerful genetic test that may be performed on embryos during IVF treatment to screen for numerical chromosomal abnormalities. PGS testing helps IVF physicians and patients decide which embryos to transfer.

Sate-of-art NGS based PGS accelerate  to maximize the accuracy & efficacy of embryo selection by whole genome sequencing technology.

GENOBRO

GENOBENET

Newborn Screening (NBS) is screening test for detecting certain specific chromosomal abnormalities of newborn baby using NGS (next-generation sequencing) and its applied analysis technology.

 Most of inborn genetic malfunctioned conditions are treatable genetic disorders.Prompt identification, intervention and treatment for these conditions can prevent death or irreversible disability.

NBS by NGS

(NGS-based Newborn Screening)

EMMA

(Endometrial Microbiom Meta Analysis)

ERA

(Endometrial Receptivity Analysis)

The ERA test is used to evaluate the stage of an endometrium to determine if a receptive or non-receptive genetic profile is present at the time of biopsy. In the case where the endometrium is non-receptive, the test enables us to find a personalized window of implantation for each patient.

EMMA provides a complete view of the endometrial bacterial composition, including pathogens causing Chronic Endometritis that can be specifically investigated in ALICE.

ERA / EMMA

810 Gwanggyo Central Biz Tower, Suwon-si, Gyeonggi-do, Republic of Korea   e-mail : info@genomecare.net

©2020 by THERAGEN GENOMECARE.

All rights reserved.